
Vale Biolabs
Vale Biolabs combines lab-grown human brain tissue, automation, and predictive AI to help researchers study brain diseases and evaluate potential treatments.
About
Vale Biolabs combines lab-grown human brain tissue, automation, and predictive AI to help researchers better understand how the brain responds to drugs and support the development of new therapies. The company develops standardised human brain organoids to monitor changes in structure, activity, and molecular responses, allowing drug developers to test treatments on human brain tissue earlier in the process.
Key facts
- Website
- vale.bio
- Employees
- 8
- Total funding
- $177K (Pre-Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 9 Nov 2026 | Pre-Seed | $177K |
Tech stack
Detected on vale.bio, last scanned 9 Nov 2026. Run your own scan
- CMS / Builders
- Framer
- Email provider
- Google Workspace
Test your Effective DR
The visibility a domain actually gets, set beside its Ahrefs DR. About a minute.
Frequently asked
Is Vale Biolabs trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Vale Biolabs is 76 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Vale Biolabs raised?
Vale Biolabs has raised a total of $177K in funding. The most recent round on record is Pre-Seed.
How many employees does Vale Biolabs have?
Vale Biolabs has approximately 8 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Vale Biolabs:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

